Merck’s 23 immune & oncology pipelines accelerated towards commercialization

Published: 2018-05-11 17:20:38

Updated: 2018-05-11 17:20:38

Merck, a global pharmaceutical company, showed a strong will to develop new drugs related to oncology by revealing immune and oncology pipelines being developed by the company.

Professor Morihiro Watanabe taking in charge of the clinical development of Merch Serono introduced the company’s immune and oncology pipelines at BIO Korea 2018 held at the COEX on the 9^th.

According to Professor Wata...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.